A new trading day began on Friday, with Vor Biopharma Inc (NASDAQ: VOR) stock price down -4.60% from the previous day of trading, before settling in for the closing price of $1.63. VOR’s price has ranged from $0.63 to $3.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 17.88%. With a float of $20.91 million, this company’s outstanding shares have now reached $68.66 million.
The extent of productivity of a business whose workforce counts for 168 workers is very important to gauge. In terms of profitability, gross margin is 77.63%, operating margin of -965.14%, and the pretax margin is -919.87%.
Vor Biopharma Inc (VOR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vor Biopharma Inc is 69.55%, while institutional ownership is 83.48%. The most recent insider transaction that took place on Dec 27 ’24, was worth 12,918. In this transaction CHIEF MEDICAL OFFICER of this company sold 10,334 shares at a rate of $1.25, taking the stock ownership to the 81,439 shares. Before that another transaction happened on Dec 27 ’24, when Company’s Officer proposed sale 10,334 for $0.84, making the entire transaction worth $8,660.
Vor Biopharma Inc (VOR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.88% per share during the next fiscal year.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Here are Vor Biopharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
The latest stats from [Vor Biopharma Inc, VOR] show that its last 5-days average volume of 1.6 million was superior to 1.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.16%. Additionally, its Average True Range was 0.16.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 79.06%, which indicates a significant increase from 75.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 219.09% in the past 14 days, which was higher than the 117.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9686, while its 200-day Moving Average is $1.1450. Now, the first resistance to watch is $1.6531. This is followed by the second major resistance level at $1.7513. The third major resistance level sits at $1.8278. If the price goes on to break the first support level at $1.4784, it is likely to go to the next support level at $1.4019. Assuming the price breaks the second support level, the third support level stands at $1.3037.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
With a market capitalization of 106.79 million, the company has a total of 68,674K Shares Outstanding. Currently, annual sales are 0 K while annual income is -117,863 K. The company’s previous quarter sales were 0 K while its latest quarter income was -27,559 K.
